Science Daily8d
Key factors that impact long-term weight loss in patients prescribed GLP-1 RA medications
A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...
Key factors identified that can impact long-term weight loss in patients with obesity prescribed GLP-1 RA medications
A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...
Daily6d
Cleveland Clinic Study Identifies Key Factors Influencing Long-Term Weight Loss with GLP-1 RA Medications
A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...
Medscape10d
Longer Acting GLP-1 Receptor Agonists and the Potential for Improved Cardiovascular Outcomes
GLP-1: Glucagon-like peptide-1; RA: receptor agonist ... with similar numbers of events versus active treatment comparators. Small studies in animals and humans have shown GLP1 to also have ...
headtopics12d
GLP-1 RA Therapy for Alcohol Use Disorder?
Also, we see that, for instance, with certain individuals, when they take GLP-1 RA therapy, they might have a lot of gastrointestinal side effects. One challenge we have in the addiction field is that ...
thecardiologyadvisor.com3d
GLP-1 Receptor Agonists vs SGLT2 Inhibitors and Kidney, Heart Outcomes in T2D
Clinical trials are needed to directly compare SGLT2i and GLP-1 RA in people with and without T2D over longer follow-up durations. Covariates for propensity score analyses were chosen a priori and ...